Dermatology News Dermatologists Now Offer Non Invasive Skin Tightening Fri, 20 Nov 2009 01:00:00 PST The University of Alabama at Birmingham (UAB) Department of Dermatology is offering a new non-surgical, needle-free skin-tightening procedure that doctors say smoothes wrinkles, firms up baggy or loose skin and improves body contours. The outpatient cosmetic procedure is performed with Thermage®, a device that contours skin all over the body face, eyelids, neck, abdomen, arms, legs and more using focused radio waves. Burns Patients Awaiting Skin Grafts: Human Embryonic Stem-Cells Could Be Used To Generate Temporary Skin Fri, 20 Nov 2009 00:00:00 PST A study in this week's edition of The Lancet reports that the use of human embryonic stem-cells (hESCs) is a promising alternative for producing temporary skin substitutes for patients awaiting skin grafts after, for example, serious burn injuries. The article is the work of Dr Christine Baldeschi, INSERM and Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, Evry Cedex, France, and colleagues. FDA Approves New Drug For Pain That Persists After Shingles Wed, 18 Nov 2009 11:00:00 PST The US Food and Drug Administration (FDA) announced yesterday that it has approved Qutenza (capsaicin) 8% patch for the treatment of post-herpetic neuralgia (PHN), an often excruciating pain that can persist for weeks, months and even years in 10 to 15 per cent of people who get shingles. The medicated skin patch, which is made by Lohmann Therapie-Systems AD of Andernach, Germany and distributed in the US by NeurogesX Inc. Basilea's Toctino(R) Receives Marketing Authorization In Canada Wed, 18 Nov 2009 09:00:00 PST Basilea Pharmaceutica Ltd. announces that Toctino® (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has obtained regulatory approval from Health Canada. "We are delighted that Health Canada has approved the use of Toctino for patients with severe chronic hand eczema unresponsive to potent topical steroids. University Of Montreal Study Reveals Danger To Fetus Of Certain Drugs Wed, 18 Nov 2009 06:00:00 PST More than six percent of expectant mothers in Quebec consume prescription drugs that are known to be harmful to their fetuses, according to a Université de Montréal investigation published in the British Journal of Obstetrics and Gynaecology. Half these women will voluntarily terminate their pregnancy fearing congenital malformations, which means the abortion rate among these women is 11 percent higher than in the rest of the population. |